Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
Ratings
Exelixis’s Strategic Positioning and Market Prospects Justify Buy Rating Amid RCC Treatment Dynamics
2d ago
EXEL
Premium
Ratings
Buy Rating Affirmed for Exelixis: Promising Phase 3 Trial Results and Favorable Valuation Despite Safety Concerns
3d ago
EXEL
Premium
The Fly
Midday Fly By: GM, Coca-Cola report Q3 beats
9d ago
GE
GM
Premium
The Fly
Goldman downgraded, Coinbase initiated: Wall Street’s top analyst calls
9d ago
ES
GS
Premium
The Fly
Exelixis price target lowered to $44 from $50 at Morgan Stanley
9d ago
EXEL
Premium
The Fly
Exelixis price target lowered to $30 from $36 at Wells Fargo
9d ago
EXEL
Premium
The Fly
Leerink upgrades Exelixis to Outperform following ESMO presentation
9d ago
EXEL
Premium
The Fly
Exelixis upgraded to Outperform from Market Perform at Leerink
9d ago
EXEL
Premium
Ratings
Exelixis’s Zanzalintinib Shows Promise in Phase III Trial, Justifying Buy Rating Despite Safety Concerns
10d ago
EXEL
Premium
The Fly
Midday Fly By: AWS hit by outage, Kering sells beauty unit
10d ago
BA
DX
Premium
The Fly
Exelixis falls -12.8%
10d ago
EXEL
Premium
The Fly
Exelixis falls -12.5%
10d ago
EXEL
Premium
The Fly
Morning Movers: Cleveland-Cliffs surges following earnings report
10d ago
CLF
COO
Premium
Ratings
Exelixis’s Zanza: A Strong Contender with Promising Survival Rates and Manageable Safety Profile
10d ago
EXEL
Premium
The Fly
Exelixis reports detailed results from STELLAR-303
10d ago
EXEL
Premium
The Fly
Exelixis announces results from analysis of CABINET Phase 3 trial of CABOMETYX
11d ago
EXEL
Premium
Ratings
Exelixis: Buy Rating Backed by Strategic Positioning and Growth Prospects
15d ago
EXEL
Premium
Ratings
Exelixis Hold Rating: Modest Sales Forecasts and Competitive Challenges Amid Upcoming STELLAR-303 Data
16d ago
EXEL
Premium
Ratings
Optimistic Buy Rating for Exelixis Amid Promising Phase III Trial Results for Zanzalintinib
29d ago
EXEL
Premium
The Fly
Netflix upgraded, Five Below initiated: Wall Street’s top analyst calls
1M ago
Z
KR
Premium
Ratings
Exelixis: Strong Growth Potential with Promising Zanzalintinib Outlook and Attractive Investment Opportunity
1M ago
EXEL
Premium
The Fly
Exelixis price target raised to $50 from $46 at Morgan Stanley
1M ago
EXEL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
